Bottom line
Is VBCG a good fund? The bottom line
VBCG is an index target-date ETF from Vanguard.
Its expense ratio is 0.08% — about $8 a year on every $10,000 invested, cheaper than 95% of target-date funds we track.
With $10.6 million in net assets and 350 holdings, its largest position is Wells Fargo & Co (1.5%) and the top 10 make up 11% of the portfolio.
What stands out
- Low cost: cheaper than 95% of target-date peers
- Broadly diversified (350 holdings)
What to watch
- Small fund ($10.6 million) — small funds are likelier to close
Updated Nov 19, 2026
What VBCG invests in
Vanguard Target Maturity 2033 Corporate Bond ETF (the Fund) seeks to track the performance of a market-weighted index composed of U.S. dollar-dominated, investment-grade corporate bonds maturing in 2033.
The Fund employs an indexing investment approach designed to track the performance of the ICE 2033 Maturity US Corporate Constrained Index (the Target Index). The Target Index has a planned liquidation on or about December 15, 2033, and includes U.S. dollar-denominated, investment-grade corporate bonds scheduled to mature between January 1, 2033 and December 15, 2033. Under normal circumstances, the Fund invests at least 80% of its net assets, plus the amount of any borrowings for investment purposes, in the components of the Target Index or in securities determined by the Funds advisor to have economic characteristics substantially identical to those of the Target Index components. The Fund is a term fund that will liquidate on or about December 15, 2033 (the Planned Liquidation Date). The Fund does not seek to return any predetermined amount at liquidation or in periodic…
From the fund's prospectus (filed Mar 23, 2026).
What VBCG costs
On a $10,000 investment, VBCG's 0.08% expense ratio costs about $8 a year. The median target-date fund charges 0.59%.
VBCG top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Wells Fargo & Co | 1.54% |
| 2 | Bank of America Corp | 1.42% |
| 3 | Morgan Stanley | 1.34% |
| 4 | Pfizer Investment Enterprises Pte Ltd | 1.28% |
| 5 | JPMorgan Chase & Co | 1.04% |
| 6 | Goldman Sachs Group Inc/The | 0.93% |
| 7 | JPMorgan Chase & Co | 0.89% |
| 8 | Oracle Corp | 0.87% |
| 9 | Amgen Inc | 0.87% |
| 10 | Wells Fargo & Co | 0.85% |
Source: SEC Form N-PORT, period ended Jun 30, 2026
The top 10 make up 11% of the fund. See all top 25 holdings and asset mix →